No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19

Autor: Kenneth Sands, Richard Wenzel, Laura McLean, Kimberly Korwek, Jonathon Roach, Karla Miller, Russell E. Poland, L. Hayley Burgess, Edmund Jackson, Jonathan B. Perlin

Publikováno v: International Journal of Infectious Diseases, Vol 104, Iss , Pp 34-40 (2021)

Background: The use of hydroxychloroquine (HCQ), with or without concurrent administration of azithromycin (AZM), for treatment of COVID-19 has received considerable attention. The purpose of this study was to determine whether HCQ administration is

Externí odkaz: https://doaj.org/article/da38df00503f45af888f585c1b22b4cb

A Pharmacist’s Reflection: Living a week, when death’s four seconds away

Autor: Richard Wenzel, PharmD, CPPS

Publikováno v: INNOVATIONS in Pharmacy, Vol 7, Iss 3 (2016)

Conflict of Interest I declare no conflicts of interest or financial interests that the author or members of his immediate family have in any product or service discussed in the manuscript, including grants (pending or received), employment, gifts,

Externí odkaz: https://doaj.org/article/136492df3039481489b294fb52337fad

Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis

Autor: Jessica, Ailani, Jeffrey Scott, Andrews, Antje, Tockhorn-Heidenreich, Richard, Wenzel, Mallikarjuna, Rettiganti

Publikováno v: Advances in Therapy. 39:4544-4555

In evaluating therapies for migraine prevention, emphasis is placed on frequency and less attention is paid to duration or severity. Total pain burden (TPB) combines frequency, duration, and severity of migraine headache, and has the potential to fur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e37d16d1177da1f7f1a02bdba0ab7fe
https://doi.org/10.1007/s12325-022-02233-y

Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review

Autor: David W. Dodick, Peter J. Goadsby, Messoud Ashina, Cristina Tassorelli, Hans‐Peter Hundemer, Jennifer N. Bardos, Richard Wenzel MD, Phebe Kemmer, Robert Conley, James M. Martinez, Tina Oakes

Publikováno v: Headache
Dodick, D W, Goadsby, P J, Ashina, M, Tassorelli, C, Hundemer, H-P, Bardos, J N, Wenzel, R, Kemmer, P, Conley, R, Martinez, J M & Oakes, T 2022, ' Challenges and complexities in designing cluster headache prevention clinical trials : A narrative review ', Headache, vol. 62, no. 4, pp. 453-472 . https://doi.org/10.1111/head.14292

Objective: To provide a review of challenges in clinical trials for the preventive treatment of cluster headache (CH) and highlight considerations for future studies. Background: Current guidelines for preventive treatment of CH are largely based on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::903a1596c58a617f789357b05e08ce93
https://doi.org/10.1111/head.14292

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment

Autor: Phebe Kemmer, Miguel J. A. Láinez, Mark E. Bangs, Jean Schoenen, Tina M. Oakes, Jennifer N. Bardos, Chad Stroud, James M. Martinez, Richard Wenzel, Dulanji K. Kuruppu

Publikováno v: Headache: The Journal of Head and Face Pain. 62:65-77

Objective The objective of the study was to assess the tolerability and safety of galcanezumab in patients with chronic cluster headache (CH) with up to 15 months of treatment. Background Chronic CH is a highly debilitating disease with a substantial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c99d053dd936ae8c5d80e8a42312db0
https://doi.org/10.1111/head.14234